Celyad SA Banner Image

Celyad SA

  • Ticker CYAD
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Celyad SA Logo Image
  • 51-200 Employees
  • Based in Mont-Saint-Guibert, Belgium
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. The Company is developing a pipeline of allogeneic (off-the-shelf) and autologous (personalized) CAR T cell therapy candidates for the treatment of both hematological malignancies and solid tumors. Celyad Oncology was foundedMore in 2007 and is based in Mont-Saint-Guibert, Belgium and New York, NY. The Company has received funding from the Walloon Region (Belgium) to support the advancement of its CAR T cell therapy programs.
4.7 / 5.0 (84)

Celyad SA reports have an aggregate usefulness score of 4.7 based on 84 reviews.

Celyad SA

Most Recent Annual Report

Celyad SA
MOST RECENT 2023 Annual Report

Older/Archived Annual Reports

Celyad SA Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!